Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus

Journal of Dermatology

Volumn 38, Issue 4, 2011, Pages 335-344

  Ohno, Seiji ^a   Tateishi, Yoshihisa ^b   Tatemoto, Yukihiro ^b   Morishita, Keiko ^a   Sasabe, Eri ^a   Yamamoto, Tetsuya ^a  

^a KOCHI UNIVERSITY   (Japan)

^b Kochi Health Sciences Center   (Japan)

Author keywords

cDNA microarray; cytokines; monocytes; oral lichen planus; Toll like receptors

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 12; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; CYTOKINE; MESSENGER RNA; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; CASE CONTROL STUDY; DNA MICROARRAY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 79953072736     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00956.x     Document Type: Article

References (39)

1. Gonzalez-Moles MA, Scully C, Gil-Montoya JA,. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis 2008; 14: 229-243. (Pubitemid 351379716)
2. Scully C, Carrozzo M,. Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 2008; 46: 15-21. (Pubitemid 350266149)
3. Akira S, Uematsu S, Takeuchi O,. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801. (Pubitemid 43261452)
4. Medzhitov R,. Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 819-826. (Pubitemid 47598622)
5. Kumar H, Kawai T, Akira S,. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388: 621-625.
6. Asea A,. Heat shock proteins and toll-like receptors. Handb Exp Pharmacol 2008; 183: 111-127.
7. Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H,. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 2008; 27: 218-224.
8. Lai Y, Gallo RL,. Toll-like receptors in skin infectious and inflammatory diseases. Infect Disord Drug Targets 2008; 8: 144-155.
9. Fischer M, Ehlers M,. Toll-like receptors in autoimmunity. Ann NY Acad Sci 2008; 1143: 21-34.
10. Srinivasan M, Kodumudi KN, Zunt SL,. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin Immunol 2008; 126: 31-37. (Pubitemid 350266449)
11. Zunt SL, Burton LV, Goldblatt LI, Dobbins EE, Srinivasan M,. Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cell. Clin Exp Immunol 2009; 156: 285-293.
12. Tomioka H, Morita K, Hasegawa S, Omura K,. Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med 2006; 35: 206-211. (Pubitemid 43362951)
13. Odani T, Ito D, Li MH, et al. Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology. Int J Oncol 2006; 28: 619-624.
14. Vigneswaran N, Beckers S, Waigel S, et al. Increased EMMPRIN (CD147) expression during oral carcinogenesis. Exp Mol Pathol 2006; 80: 147-159.
15. Ichimura M, Hiratsuka K, Ogura N, et al. Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. J Oral Pathol Med 2006; 35: 167-174.
16. Tao XA, Li CY, Xia J, et al. Differential gene expression profiles of whole lesions from patients with oral lichen planus. J Oral Pathol Med 2009; 38: 427-433.
17. Kupper TS, Fuhlbrigge RC,. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004; 4: 211-222. (Pubitemid 38339087)
18. Sugita K, Kabashima K, Atarashi K, Shimauchi T, Kobayashi M, Tokura Y,. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol 2007; 147: 176-183. (Pubitemid 44915569)
19. Baker BS, Ovigne JM, Powles AV, et al. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 2003; 148: 670-679. (Pubitemid 36629744)
20. Köllisch G, Kalali BN, Voelcker V, et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005; 114: 531-541. (Pubitemid 40478147)
21. Lebre MC, van der Aar AM, van Baarsen L, et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 2007; 127: 331-341. (Pubitemid 46106911)
22. Sugawara Y, Uehara A, Fujimoto Y, et al. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 2006; 85: 524-529. (Pubitemid 43945490)
23. Liu S, Salyapongse AN, Geller DA, Vodovotz Y, Billiar TR,. Hepatocyte toll-like receptor 2 expression in vivo and in vitro: role of cytokines in induction of rat TLR2 gene expression by lipopolysaccharide. Shock 2000; 14: 361-365.
24. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M,. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001; 166: 2018-2024. (Pubitemid 32114690)
25. Beutler B,. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430: 257-263. (Pubitemid 38902439)
26. Yamamoto T, Osaki T, Yoneda K, Ueta E,. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. J Oral Pathol Med 1994; 23: 309-315. (Pubitemid 2131401)
27. Yamamoto T, Osaki T,. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995; 104: 784-788.
28. Pivarcsi A, Bodai L, Réthi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15: 721-730. (Pubitemid 36675803)
29. Begon E, Michel L, Flageul B, et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 2007; 17: 497-506. (Pubitemid 350207160)
30. Frolova L, Drastich P, Rossmann P, Klimesova K, Tlaskalova-Hogenova H,. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem 2008; 56: 267-274. (Pubitemid 351272998)
31. Yamamoto T, Yoneda K, Ueta E, Osaki T,. Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral Pathol 1994; 78: 727-735.
32. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM,. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006; 80: 866-874. (Pubitemid 43062898)
33. Niessner A, Steiner S, Speidl WS, et al. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 2006; 189: 408-413. (Pubitemid 44634488)
34. Marsik C, Mayr F, Cardona F, Derhaschnig U, Wagner OF, Jilma B,. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol 2003; 121: 653-656. (Pubitemid 36645389)
35. Spellberg B, Edwards JE Jr,. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32: 76-102. (Pubitemid 32150953)
36. Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol 1999; 44: 499-507. (Pubitemid 29264470)
37. Fayyazi A, Schweyer S, Soruri A, et al. T lymphocytes and altered keratinocytes express interferon-gamma and interleukin 6 in lichen planus. Arch Dermatol Res 1999; 291: 485-490. (Pubitemid 29484128)
38. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB,. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003; 32: 77-83. (Pubitemid 36608883)
39. Kalogerakou F, Albanidou-Farmaki E, Markopoulos AK, Antoniades DZ,. Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. Hippokratia 2008; 12: 230-235.